HomepageEarnings Events Newsdesk 23 hours ago Regeneron Pharmaceuticals Inc (REGN) Olatorepatide Obesity Treatment Licensed by Regeneron Demonstrates Positive Phase 3 Results in Chinese Patients Regeneron Pharmaceuticals Inc (NASDAQ: REGN) FY 2026 Other Release Zoetis Inc (ZTS) Barclays 28th Annual Global Healthcare Conference » « United Therapeutics Corporation (UTHR) United Therapeutics Corporation Announces $2 Billion Stock Repurchase Authorization and Enters into $1.5 Billion Accelerated Share Repurchase Program Newsdesk: